TRAVERE THERAPEUTICS, INC. (TVTX)

65.67 -2.74% (-1.85)

Over 1M: +17.5%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

55 60 65
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 68.2M Q3 '21 — Operating Cash Flow: 32.1M Q3 '21 — Free Cash Flow: 31.7M Q3 '21 — Net Income: -35.6M Q4 '21 — Operating Cash Flow: -26.9M Q4 '21 — Free Cash Flow: -27M Q4 '21 — Net Income: -51.6M Q1 '22 — Revenue: 48.5M Q1 '22 — Operating Cash Flow: -55.3M Q1 '22 — Free Cash Flow: -55.5M Q1 '22 — Net Income: -76M Q2 '22 — Revenue: 54.2M Q2 '22 — Operating Cash Flow: -36.8M Q2 '22 — Free Cash Flow: -36.8M Q2 '22 — Net Income: -67M Q3 '22 — Revenue: 28.1M Q3 '22 — Operating Cash Flow: -39.5M Q3 '22 — Free Cash Flow: -39.5M Q3 '22 — Net Income: -69.7M Q4 '22 — Revenue: 29.3M Q4 '22 — Operating Cash Flow: -54.6M Q4 '22 — Free Cash Flow: -54.7M Q4 '22 — Net Income: -65.8M Q1 '23 — Revenue: 30.9M Q1 '23 — Operating Cash Flow: -81.1M Q1 '23 — Free Cash Flow: -81.7M Q1 '23 — Net Income: -86.3M Q2 '23 — Revenue: 32.2M Q2 '23 — Operating Cash Flow: -69.3M Q2 '23 — Free Cash Flow: -69.3M Q2 '23 — Net Income: -85.6M Q3 '23 — Revenue: 37.1M Q3 '23 — Operating Cash Flow: -59.1M Q3 '23 — Free Cash Flow: -59.1M Q3 '23 — Net Income: 150.7M Q4 '23 — Revenue: 45.1M Q4 '23 — Operating Cash Flow: -70.5M Q4 '23 — Free Cash Flow: -70.5M Q4 '23 — Net Income: -90.2M Q1 '24 — Revenue: 41.4M Q1 '24 — Operating Cash Flow: -119M Q1 '24 — Free Cash Flow: -119M Q1 '24 — Net Income: -136.1M Q2 '24 — Revenue: 54.1M Q2 '24 — Operating Cash Flow: -40.2M Q2 '24 — Free Cash Flow: -40.3M Q2 '24 — Net Income: -70.4M Q3 '24 — Revenue: 62.9M Q3 '24 — Operating Cash Flow: -42.5M Q3 '24 — Free Cash Flow: -42.5M Q3 '24 — Net Income: -54.8M Q4 '24 — Revenue: 74.8M Q4 '24 — Operating Cash Flow: -35.7M Q4 '24 — Net Income: -60.3M Q1 '25 — Revenue: 81.7M Q1 '25 — Operating Cash Flow: -42.2M Q1 '25 — Net Income: -41.2M Q2 '25 — Revenue: 114.4M Q2 '25 — Operating Cash Flow: 5M Q2 '25 — Net Income: -12.8M Q3 '25 — Revenue: 164.9M Q3 '25 — Operating Cash Flow: 14.3M Q3 '25 — Free Cash Flow: 14.2M Q3 '25 — Net Income: 25.7M Q4 '25 — Revenue: 129.7M Q4 '25 — Net Income: 2.7M Q1 '26 — Revenue: 127.2M Q1 '26 — Operating Cash Flow: -40.4M Q1 '26 — Net Income: -37.1M Q2 '26 — Revenue: 169.6M Q2 '26 — Operating Cash Flow: 58.1M Q2 '26 — Net Income: -34.8M -70M 0 70M 140M 210M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.0
SBC / sales 10.3%
OE margin -3.9%
Oper. margin -6.8%
ROIC -75.0%
Accruals -10.2%
Gross margin 98.6%
FCF margin 6.4%
OCF margin 6.4%
ROA -5.4%
ROCE -6.2%
ROE -177.2%
Capex / sales —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.8
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

5.8
ND/EBITDA —
Debt payback 0.48 yr
Quick ratio 3.8×
Cash / Debt 0.94×
F-score 6.8 pts
Net debt / Eq 0.74×
Debt / Eq 12.7×
Cash runway —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

8.2
Sales/sh Y/Y +56.6%
Sales CAGR 4Y +38.9%
Sales Q/Q +48.2%
Shares change +13.1%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.